4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0001193125-26-294478
Chief Medical Officer sold 373 shares at $34.73 ($12,954)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Simon Amy Chief Medical Officer | 2026-06-30 | Sale 10b5-1 | −373 | $34.73 | $12,954 | 102,363 | D: show line 1 in the form |
| Open-market sales · 373 sh · avg $34.73 · $12,954 | |||||||
Loading xslF345X06/ownership.xml…